Alaunos Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2021 to Q2 2024.
  • Alaunos Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Alaunos Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Interest Expense for 2023 was $1.92M, a 39.1% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Interest Expense for 2022 was $3.15M, a 165% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 -$1.07M -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.07M $0 -$853K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.92M $0 -$890K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.81M $0 -$841K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.65M $1.07M +$328K +44.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $3.32M $853K +$170K +24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.15M $890K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $841K +$397K +89.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $740K +$740K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $683K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 $444K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.